Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Dew and Boing my recollection is the same and there definitely appears to be disharmony between what was said in court and what investors were told in Amphastar's report referenced by Dew. The only way I am able to reconcile this is a little far fetched but implied in the recordings of the recent court hearing: if I understand this correctly, it appears that Momenta's patent is used to identify impurities that are discarded leaving behind the pure product, (product is taken off the production line--not added) hence my analogy earlier of the statue within the stone. So technically the patent and I know this is a stretch, is used in the " reduction" of the product not the production! I believe Ampha is capable of trying to define what "is" is, especially in light of the way they withheld information from the courts and were sanctioned before as noted by Boing. I think Ampha could just be parsing here. Too crazy? Maybe, just trying to make sense of it all and I am very appreciative of those that have helped me along the way. Regards, bp